| Tretinoin | Approved Investigational Nutraceutical | CYB5R1 | 51706 |
upregulated | Tretinoin results in increased expression of CYB5R1 mRNA | 1q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CYB5R2 | 51700 |
upregulated | Tretinoin results in increased expression of CYB5R2 mRNA | 11p15.4 | |
| Tretinoin | Approved Investigational Nutraceutical | CYBA | 1535 |
upregulated | Tretinoin results in increased expression of CYBA mRNA | 16q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CYBB | 1536 |
upregulated | Tretinoin results in increased expression of CYBB mRNA | Xp21.1-p11.4 | |
| Tretinoin | Approved Investigational Nutraceutical | CYC1 | 1537 |
downregulated | Tretinoin results in decreased expression of CYC1 mRNA | 8q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CYFIP2 | 26999 |
upregulated | Tretinoin results in increased expression of CYFIP2 mRNA | 5q33.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CYGB | 114757 |
downregulated | Tretinoin results in decreased expression of CYGB mRNA | 17q25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CYHR1 | 50626 |
upregulated | Tretinoin results in increased expression of CYHR1 mRNA | 8q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP11A1 | 1583 |
upregulated | Tretinoin results in increased expression of CYP11A1 mRNA | 15q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP17A1 | 1586 |
upregulated | Tretinoin results in increased expression of CYP17A1 mRNA | 10q24.32 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP19A1 | 1588 |
upregulated | Tretinoin results in increased expression of CYP19A1 mRNA | 15q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP1A1 | 1543 |
downregulated | Tretinoin results in decreased expression of CYP1A1 mRNA | 15q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP1A1 | 1543 |
upregulated | Tretinoin results in increased expression of CYP1A1 mRNA | 15q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP1A2 | 1544 |
downregulated | Tretinoin results in decreased expression of CYP1A2 mRNA | 15q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP1A2 | 1544 |
upregulated | Tretinoin results in increased expression of CYP1A2 mRNA | 15q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP1B1 | 1545 |
upregulated | Tretinoin results in increased expression of CYP1B1 mRNA | 2p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP24A1 | 1591 |
upregulated | Tretinoin results in increased expression of CYP24A1 mRNA | 20q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP26A1 | 1592 |
upregulated | Tretinoin metabolite results in increased expression of CYP26A1 mRNA | 10q23.33 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP26A1 | 1592 |
upregulated | Tretinoin results in increased expression of CYP26A1 mRNA | 10q23.33 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP26B1 | 56603 |
upregulated | Tretinoin results in increased expression of CYP26B1 mRNA | 2p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP26C1 | 340665 |
upregulated | Tretinoin results in increased expression of CYP26C1 mRNA | 10q23.33 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP2A13 | 1553 |
upregulated | Tretinoin results in increased expression of CYP2A13 mRNA | 19q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP2A6 | 1548 |
upregulated | Tretinoin results in increased expression of CYP2A6 mRNA | 19q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP2C18 | 1562 |
downregulated | Tretinoin results in decreased expression of CYP2C18 mRNA | 10q23.33 | |
| Tretinoin | Approved Investigational Nutraceutical | CYP2C19 | 1557 |
downregulated | Tretinoin results in decreased expression of CYP2C19 mRNA | 10q23.33 | |